Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma-Associated Herpesvirus-Infected Endothelium

Genes and Cancer

Volumn 3, Issue 7-8, 2012, Pages 512-520

  Maor, Yehoshua ^a   Yu, Jinlong ^a   Kuzontkoski, Paula M ^a   Dezube, Bruce J ^a   Zhang, Xuefeng ^a   Groopman, Jerome E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cannabidiol; Kaposi sarcoma; Kaposi sarcoma associated herpesvirus; vascular endothelial growth factor receptor 3; viral G protein coupled receptor

Indexed keywords

CANNABIDIOL; CHEMOKINE; G PROTEIN COUPLED RECEPTOR; GROWTH REGULATED PROTEIN ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ADULT; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INHIBITION KINETICS; KAPOSI SARCOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

HUMAN HERPESVIRUS 8;

EID: 84875520814     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912466556     Document Type: Article

References (58)

1. Chang Y,Cesarman E,Pessin MS, et al.Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.Science. 1994;266 (5192): 1865-9.
2. Antman K,Chang Y.Kaposi's sarcoma.N Engl J Med. 2000;342 (14): 1027-38.
3. Marcelin AG,Calvez V,Dussaix E.KSHV after an organ transplant: should we screen?.Curr Top Microbiol Immunol. 2007;312:245-62.
4. Martellotta F,Berretta M,Vaccher E, et al.AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies.Curr HIV Res. 2009;7 (6): 634-8.
5. GanemD. KSHV-induced oncogenesis. In:ArvinACampadelli-FiumeGMocarskiE., editors. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 56. Available from: http://www.ncbi.nlm.nih.gov/books/NBK47373.
6. Mesri EA,Cesarman E,Boshoff C.Kaposi's sarcoma and its associated herpesvirus.Nat Rev Cancer. 2010;10 (10): 707-19.
7. Boshoff C,Schulz TF,Kennedy MM, et al.Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.Nat Med. 1995;1 (12): 1274-8.
8. Flore O,Rafii S,Ely S, et al.Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.Nature. 1998;394 (6693): 588-92.
9. Yang TY,Chen SC,Leach MW, et al.Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.J Exp Med. 2000;191 (3): 445-54.
10. Sodhi A,Chaisuparat R,Hu J, et al.The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.Cancer Cell. 2006;10 (2): 133-43.
11. Arvanitakis L,Geras-Raaka E,Varma A,Gershengorn MC,Cesarman E.Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation.Nature. 1997;385 (6614): 347-50.
12. Cesarman E,Nador RG,Bai F, et al.Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.J Virol. 1996;70 (11): 8218-23.
13. Bais C,Santomasso B,Coso O, et al.G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.Nature. 1998;391 (6662): 86-9.
14. Burger M,Burger JA,Hoch RC, et al.Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor.J Immunol. 1999;163 (4): 2017-22.
15. Cannon M.The KSHV and other human herpesviral G protein-coupled receptors.Curr Top Microbiol Immunol. 2007;312:137-56.
16. Gershengorn MC,Geras-Raaka E,Varma A,Clark-Lewis I.Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture.J Clin Invest. 1998;102 (8): 1469-72.
17. Lane BR,Liu J,Bock PJ, et al.Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.J Virol. 2002;76 (22): 11570-83.
18. Geras-Raaka E,Arvanitakis L,Bais C, et al.Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture.J Exp Med. 1998;187 (5): 801-6.
19. Geras-Raaka E,Varma A,Ho H,Clark-Lewis I,Gershengorn MC.Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.J Exp Med. 1998;188 (2): 405-8.
20. Geras-Raaka E,Varma A,Clark-Lewis I,Gershengorn MC.Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.Biochem Biophys Res Commun. 1998;253 (3): 725-7.
21. Mechoulam R,Shvo Y.Hashish, I: the structure of cannabidiol.Tetrahedron. 1963;19 (12): 2073-8.
22. Lerner M.Marihuana: tetrahydrocannabinol and related compounds.Science. 1963;140 (3563): 175-6.
23. Izzo AA,Borrelli F,Capasso R,Di Marzo V,Mechoulam R.Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.Trends Pharmacol Sci. 2009;30 (10): 515-27.
24. McAllister SD,Christian RT,Horowitz MP,Garcia A,Desprez PY.Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.Mol Cancer Ther. 2007;6 (11): 2921-7.
25. Ramer R,Rohde A,Merkord J,Rohde H,Hinz B.Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells.Pharm Res. 2010;27 (10): 2162-74.
26. Yamada T,Ueda T,Shibata Y, et al.TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.Urology. 2010;76 (2): 509.e1-7.
27. Torres S,Lorente M,Rodriguez-Fornes F, et al.A combined preclinical therapy of cannabinoids and temozolomide against glioma.Mol Cancer Ther. 2011;10 (1): 90-103.
28. McKallip RJ,Jia W,Schlomer J, et al.Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression.Mol Pharmacol. 2006;70 (3): 897-908.
29. Marcu JP,Christian RT,Lau D, et al.Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.Mol Cancer Ther. 2010;9 (1): 180-9.
30. Mechoulam R,Peters M,Murillo-Rodriguez E,Hanus LO.Cannabidiol: recent advances.Chem Biodivers. 2007;4 (8): 1678-92.
31. Delgado T,Carroll PA,Punjabi AS, et al.Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells.Proc Natl Acad Sci U S A. 2010;107 (23): 10696-701.
32. Hansen A,Henderson S,Lagos D, et al.KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming.Genes Dev. 2010;24 (2): 195-205.
33. El-Remessy AB,Al-Shabrawey M,Khalifa Y, et al.Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.Am J Pathol. 2006;168 (1): 235-44.
34. Rajesh M,Mukhopadhyay P,Batkai S, et al.Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.Am J Physiol Heart Circ Physiol. 2007;293 (1): H610-9.
35. Zhang X,Wang JF,Kunos G,Groopman JE.Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.Cancer Res. 2007;67 (15): 7230-7.
36. Tammela T,Zarkada G,Wallgard E, et al.Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.Nature. 2008;454 (7204): 656-60.
37. Zhang X,Wang JF,Chandran B, et al.Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection.J Biol Chem. 2005;280 (28): 26216-24.
38. Carroll PA,Brazeau E,Lagunoff M.Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.Virology. 2004;328 (1): 7-18.
39. Masood R,Cesarman E,Smith DL,Gill PS,Flore O.Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.Am J Pathol. 2002;160 (1): 23-9.
40. Jussila L,Valtola R,Partanen TA, et al.Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.Cancer Res. 1998;58 (8): 1599-604.
41. Weninger W,Partanen TA,Breiteneder-Geleff S, et al.Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.Lab Invest. 1999;79 (2): 243-51.
42. Lohela M,Bry M,Tammela T,Alitalo K.VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.Curr Opin Cell Biol. 2009;21 (2): 154-65.
43. Bergamaschi MM,Queiroz RH,Chagas MH, et al.Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients.Neuropsychopharmacology. 2011;36 (6): 1219-26.
44. Bhattacharyya S,Morrison PD,Fusar-Poli P, et al.Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010;35 (3): 764-74.
45. Johnson JR,Burnell-Nugent M,Lossignol D, et al.Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.J Pain Symptom Manage. 2010;39 (2): 167-79.
46. Paudel KS,Hammell DC,Agu RU,Valiveti S,Stinchcomb AL.Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.Drug Dev Ind Pharm. 2010;36 (9): 1088-97.
47. Nokta M.Oral manifestations associated with HIV infection.Curr HIV/AIDS Rep. 2008;5 (1): 5-12.
48. Thomas A,Baillie GL,Phillips AM, et al.Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.Br J Pharmacol. 2007;150 (5): 613-23.
49. Mutlu AD,Cavallin LE,Vincent L, et al.In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.Cancer Cell. 2007;11 (3): 245-58.
50. Bechara C,Chai H,Lin PH,Yao Q,Chen C.Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions.Med Sci Monit. 2007;13 (6): RA87-90.
51. Fimmel S,Devermann L,Herrmann A,Zouboulis C.GRO-alpha: a potential marker for cancer and aging silenced by RNA interference.Ann N Y Acad Sci. 2007;1119:176-89.
52. Di Lorenzo G.Update on classic Kaposi sarcoma therapy: new look at an old disease.Crit Rev Oncol Hematol. 2008;68 (3): 242-9.
53. Karpanen T,Egeblad M,Karkkainen MJ, et al.Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.Cancer Res. 2001;61 (5): 1786-90.
54. Petrova TV,Bono P,Holnthoner W, et al.VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.Cancer Cell. 2008;13 (6): 554-6.
55. Bais C,Van Geelen A,Eroles P, et al.Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR.Cancer Cell. 2003;3 (2): 131-43.
56. Bahram F,Claesson-Welsh L.VEGF-mediated signal transduction in lymphatic endothelial cells.Pathophysiology. 2010;17 (4): 253-61.
57. Shiels MS,Pfeiffer RM,Gail MH, et al.Cancer burden in the HIV-infected population in the United States.J Natl Cancer Inst. 2011;103 (9): 753-62.
58. Vieira J,O'Hearn P,Kimball L,Chandran B,Corey L.Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.J Virol. 2001;75 (3): 1378-86.